Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   BINA   SUMMER 2012 , Volume 17 , Number 4 (69); Page(s) 363 To 368.
 
Paper: 

ORAL PROPRANOLOL FOR TREATMENT OF PEDIATRIC HEMANGIOMA (LONG-TERM FOLLOW-UP)

 
 
Author(s):  ALETAHA M.*, SALOOR H., BAGHERI A., RAFATI N., AMOOHASHEMI N.
 
* OPHTHALMIC RESEARCH CENTER, SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, IRAN
 
Abstract: 

Purpose: To assess the effect and long-term results of oral propranolol in pediatric capillary hemangiomas.
Methods: Four children aged 3 months to 5 years with periocular and orbital hemangioma of infancy (HOI) were treated with propranolol, 2 milligram per kilogram per day divided in 2 doses. Propranolol was continued in all cases until the end of the first year of life and tapered over 2-3 weeks.
Results: Significant improvement was noted in all patients in the first 2 months of treatment and continued slowly during the follow-up. No serious complications were observed during the follow-up period.
Conclusion: Oral propranolol can be used as the first line treatment in children with capillary hemangioma.

 
Keyword(s): PEDIATRIC HEMANGIOMA, ORAL PROPRANOLOL, CASE SERIES, TREATMENT
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 55
 
Latest on Blog
Enter SID Blog